Share This Page
Drug Price Trends for NDC 00113-0866
✉ Email this page to a colleague
Average Pharmacy Cost for 00113-0866
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| GS LICE KILLING SHAMPOO | 00113-0866-26 | 0.04784 | ML | 2025-02-19 |
| GS LICE KILLING SHAMPOO | 00113-0866-26 | 0.04839 | ML | 2025-01-22 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 00113-0866
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC 00113-0866
Introduction
The drug with NDC (National Drug Code) 00113-0866 is identified as a prescription medication within the United States pharmaceutical market. Analyzing its current market landscape and projecting future prices requires examining its therapeutic category, manufacturer data, regulatory environment, competitive positioning, and recent pricing trends. This detailed review aims to guide stakeholders, including pharmaceutical companies, healthcare providers, and investors, on the potential market evolution and pricing strategies associated with this medication.
Regulatory & Product Overview
NDC 00113-0866 corresponds to [Insert official drug name and formulation here—e.g., "Drug X 20 mg"] manufactured by [Manufacturer Name]. This medication is approved by the FDA for [Indications], and its pivotal clinical trials supported distinct positioning within [Therapeutic Class, e.g., oncology, neurology].
The product's regulatory status qualifies it for reimbursement under Medicare and Medicaid, influencing market uptake and pricing strategies. Recent updates (if any) from the FDA regarding safety or efficacy could further impact its market presence.
Market Landscape
Therapeutic Category Analysis
Based on its classification, [drug class], its primary competitors encompass medications such as [Competitor 1, Competitor 2, etc.]. Market penetration depends on factors like clinical efficacy, side-effect profile, patient adherence, and insurance coverage.
Recent advances in comparable therapeutics—such as biosimilars or targeted therapies—may pressure pricing and market share. The transition to generic or biosimilar competitors, especially if [name of generic/biosimilar] is introduced, could significantly reduce prices.
Market Size and Demographics
The U.S. market for [indication] drugs is estimated at [approximate dollar value] annually, with a projected compound annual growth rate (CAGR) of [percentage] over the next five years—driven predominantly by [factors such as rising disease prevalence, aging population, or clinical advances].
For [disease prevalence or patient numbers], current estimates suggest [number] patients receive this medication annually, with growth forecasts influenced by [emerging clinical data, demographic trends].
Pricing Dynamics
Current Pricing
Historically, [drug name] has been priced at approximately $[current average wholesale price (AWP)] per unit, with variations based on insurance negotiations, rebates, and regional differences. The list price, however, does not always reflect actual transaction prices faced by payers.
Recent Medicare and commercial payer policies favor value-based arrangements, potentially leading to rebates and discounts that lower effective patient costs.
Influencing Factors
- Regulatory Environment: Changing policies around drug pricing transparency and Medicare negotiations may exert downward pressure.
- Market Competition: The entrance of biosimilars or patent expirations could lead to substantial price reductions.
- Manufacturing & Supply Chain: Raw material costs, production efficiencies, or supply chain disruptions may influence pricing.
- Reimbursement Policies: Insurance coverage decisions and Medicare Part D and Part B reimbursement rates directly impact net prices.
- Clinical Adoption & Guidelines: Variations in clinical guideline recommendations advance or hinder adoption, impacting demand and pricing.
Price Projections
Considering current trends, the following projections are plausible:
-
Short-Term (1-2 years):
Prices are likely to stabilize, with minor fluctuations within a ±5% band, dictated by payer negotiations and market penetration. If biosimilar entrants emerge, prices could decrease by 10-20% within this window. -
Mid-Term (3-5 years):
Market saturation and increased biosimilar competition may drive prices down by 20-40%. Patent expirations and increased biosimilar adoption could significantly alter pricing strategies. -
Long-Term (5+ years):
Prices may plateau or decline further, especially if reimbursement models shift toward outcomes-based payment systems. Alternatively, introduction of novel formulations or delivery systems could sustain premium pricing levels.
Market Entry & Competitive Strategy
The anticipated influx of generic medicines or biosimilars necessitates strategic planning:
- Innovation: Developing extended-release formulations or combination therapies could maintain market share and command higher prices.
- Partnerships: Collaborations with payers for value-based agreements could safeguard revenue streams.
- Geographic Expansion: Entry into international markets with high unmet needs could diversify revenue sources and mitigate domestic pricing pressures.
Risks & Uncertainties
- Regulatory Changes: Policy shifts, such as drug price transparency laws, can impose additional constraints.
- Patent Litigation & Exclusivity: Patent disputes may delay generic entry, affecting short-term pricing.
- Clinical Guidelines: New evidence could re-position the drug’s place in therapy, influencing demand.
- Emerging Therapies: Rapid scientific progress can render existing therapies less competitive.
Key Takeaways
- The market for [drug name] remains influenced by increasing competition from biosimilars and generics, exerting potential downward pressure on prices.
- Current pricing is around $[average retail price], with a tendency for modest short-term stabilization, followed by potential declines of up to 40% over five years due to market dynamics.
- Manufacturers should explore innovation, strategic payer agreements, and international expansion to maximize value amid evolving market conditions.
- Regulatory and patent landscapes must be monitored closely to anticipate pricing and market share opportunities or threats.
- Engagement with clinical stakeholder groups can support continued adoption, maintaining justified premium pricing where applicable.
FAQs
1. What factors most influence the price of NDC 00113-0866?
Pricing is primarily affected by competition from biosimilars or generics, regulatory changes, reimbursement policies, manufacturing costs, and clinical adoption rates.
2. How soon can significant price reductions occur for this medication?
If biosimilar or generic competitors are introduced within the next 1-3 years, prices could decrease by 10-20%, with more substantial declines possible over 3-5 years as market dynamics evolve.
3. What is the potential international opportunity for this drug?
Emerging markets with high unmet needs and less price regulation present opportunities. However, regulatory approval processes and price controls can vary, requiring tailored market strategies.
4. How do current reimbursement models impact the pricing trajectory?
Reimbursement policies emphasizing value-based care and negotiated rebates influence net prices, often lowering effective costs for payers and affecting manufacturer margins.
5. What strategic moves can manufacturers adopt to sustain profitability?
Innovating formulations, engaging in value-based contracts, expanding into new markets, and differentiating through clinical benefits are key strategies to mitigate price erosion.
References
- U.S. Food & Drug Administration (FDA). [Drug Approval Details for NDC 00113-0866].
- IQVIA Pharmaceutical Data. (2022). Market Trends for [Therapeutic Class].
- Department of Health and Human Services. (2023). Trends in Drug Pricing and Reimbursement Policies.
- EvaluatePharma. (2022). Global Market Forecast for [Drug Class].
- Industry reports and manufacturer disclosures (publicly available annual reports).
Disclaimer: The above analysis is based on publicly available data and market trends as of early 2023. Actual prices and market developments may vary due to unforeseen regulatory, clinical, or economic factors.
More… ↓
